Teva stock drops after conspiracy allegations on hiking drug prices
Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - Bloomberg
Teva CEO Rejects Netanyahu Plea to Salvage Jerusalem Plant - Bloomberg
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva to Pay $85 Million Settlement in Oklahoma Opioid Case - Bloomberg
Teva's Adderall Shortage Seen Continuing Into March (TEVA) - Bloomberg
Teva CEO Says Drugmaker Will Fight U.S. Price-Fixing Charges (2)
Teva (TEVA) Agrees to $225 Million Texas Opioid Settlement, AG Says - Bloomberg
Teva shares plummet amid CEO departure and bribery reports
Teva Is at Center of Drug Price-Fixing Case Filed by States - Bloomberg
Teva Pharmaceuticals to Cut 25% of Jobs in Huge Reshaping - The New York Times
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva CEO Calls 'Trough' Revenues Consequence of Patent Expirations - YouTube
Actavis CEO: Teva-Mylan deal could be "value-destroying" - Globes
Activist Investor Jana Partners Takes Stake in Teva, Report Says | Ctech
Teva Wins Ruling Tossing $235 Million Glaxo Drug Verdict - Bloomberg
Teva Sees Adderall Supply Delays Continuing for 2-3 Months (1)
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg
Teva Pharma's Short Sellers Double Down as Legal Woes Drag On - Bloomberg
Teva Negotiating Sale of Remaining Women's Health Assets, Report Says | Ctech
Teva's Credit Rating Cut to Junk by Fitch - Bloomberg
Israeli pharmaceutical company donating millions of doses of potential coronavirus drug to the U.S.
